Sort
30,917 grants matching “tumor microenvironment”
Impact of Fn14-targeted Nanoparticles for Triple-Negative Breast Cancer
$353,419Anthony J. Kim · University Of Maryland Baltimore · R37 · FY2022 · CA
Microenvironmental regulation of breast tumorigenesis
$353,419Kai Kessenbrock · University Of California-Irvine · R01 · FY2020 · CA
Microenvironmental regulation of breast tumorigenesis
$353,419Kai Kessenbrock · University Of California-Irvine · R01 · FY2021 · CA
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift of HER2+ breast cancer
$353,419Saori Furuta · University Of Toledo Health Sci Campus · R01 · FY2021 · CA
Microenvironmental regulation of breast tumorigenesis
$353,419Kai Kessenbrock · University Of California-Irvine · R01 · FY2019 · CA
Development of a Novel Approach to Immunotherapy.
$353,411Jane R Connor · Cadre Bioscience, Llc · R43 · FY2023 · CA
Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma
$353,385Linda M Liau · University Of California Los Angeles · P50 · FY2020 · CA
Heat shock proteins in cancer and signaling
$353,362Michael Y Sherman · Boston University Medical Campus · R01 · FY2006 · CA
Tumor-stromal interactions as targets of tumor metastasis suppressors
$353,351Marsha R Rosner · University Of Chicago · R01 · FY2017 · CA
Microarray Core Facility
$353,343Timothy J. Triche · University Of Southern California · P30 · FY2008 · CA
Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer
$353,329Kavitha Yaddanapudi · University Of Louisville · R01 · FY2023 · CA
Structure/Function of Protein Tyrosine Phosphatases
$353,306Zhong-Yin Zhang · Purdue University · R01 · FY2025 · CA
The hypoxic niche in glioblastoma is maintained by myeloid produced creatine
$353,256Jason Miska · Northwestern University At Chicago · R01 · FY2024 · CA
Innate Immunity and Oral Carcinogenesis
$353,250Ge Jin · Case Western Reserve University · R56 · FY2011 · DE
Adenosine in Tumor-Host Interaction
$353,239Mikhail M Dikov · Vanderbilt University · R01 · FY2012 · CA
Synergy of radiation and immunotherapy: new approaches
$353,238Yang-Xin Fu · University Of Chicago · R01 · FY2012 · CA
Synergy of radiation and immunotherapy: new approaches
$353,238Yang-Xin Fu · University Of Chicago · R01 · FY2011 · CA
Chemokine Signals in the Premetastatic Niche Inhibit Metastasis
$353,230Ann Richmond · Vanderbilt University · R01 · FY2014 · CA
Lipid Metabolism Switch Triggers Invasive and Chemoresistant Epithelial Ovarian Cancer Phenotype
$353,224Michelle R Dawson · Brown University · R01 · FY2022 · CA
Translational strategies for protecting the brain against radio- and chemotherapy
$353,202Charles Limoli · University Of California-Irvine · R01 · FY2018 · NS
Strategies to improve outcomes for TNBC patients that integrate subtype-specific genomic and immune-based discoveries
$353,192Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2019 · CA
Lipids and Myeloid Cell Function in Cancer
$353,168Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
Light-Triggered Drug Release in Primed Pancreatic Tumors
$353,140Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2013 · EB
Biological Indicators of Racial Disparity in Ameloblastoma Recurrence
$353,134Sunday O Akintoye · University Of Pennsylvania · R01 · FY2024 · CA
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy
$353,134Serge Y Fuchs · University Of Pennsylvania · R01 · FY2024 · CA